12/2/2013 11:12:01 AM
ST. LOUIS--(BUSINESS WIRE)--Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine, announced the expansion of its Cancer Genome Analysis (CGA) Suite to include additional tools for next-generation sequencing (NGS) analysis from the Broad Institute. The first addition to the suite is a method for estimating contamination levels in cancer genome data. The expanded partnership—coming just over one year after the Broad Institute named Appistry as the authorized distributor of the Genome Analysis Toolkit (GATK)—demonstrates the organizations’ commitment to developing and delivering high quality genetic analysis algorithms and tools suited to the rigors of regulated clinical sequencing workflows.
Help employers find you! Check out all the jobs and post your resume.
comments powered by